<?xml version="1.0" encoding="UTF-8"?>
<p>However, not only DRMs can affect sensitivity changes to drugs. Previous studies have shown that the virological outcomes of a therapy can be related to subtype-specific differences, pointing to the importance of analyzing the features of HIV subtypes for an improved understanding of viral subtype variability in the occurrence of DR [
 <xref rid="B13-viruses-12-00838" ref-type="bibr">13</xref>,
 <xref rid="B15-viruses-12-00838" ref-type="bibr">15</xref>,
 <xref rid="B16-viruses-12-00838" ref-type="bibr">16</xref>,
 <xref rid="B22-viruses-12-00838" ref-type="bibr">22</xref>,
 <xref rid="B32-viruses-12-00838" ref-type="bibr">32</xref>,
 <xref rid="B33-viruses-12-00838" ref-type="bibr">33</xref>,
 <xref rid="B34-viruses-12-00838" ref-type="bibr">34</xref>,
 <xref rid="B35-viruses-12-00838" ref-type="bibr">35</xref>,
 <xref rid="B36-viruses-12-00838" ref-type="bibr">36</xref>,
 <xref rid="B37-viruses-12-00838" ref-type="bibr">37</xref>,
 <xref rid="B38-viruses-12-00838" ref-type="bibr">38</xref>].
</p>
